Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA Treatment of Overactive Bladder: a Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

This study aims to show that lack of antibiotic prophylaxis to those undergoing bladder Botox injections is not significantly inferior to administering prophylaxis. By proving this, the investigators aim to decrease antibiotic use in this setting to combat the growing issue of antibiotic resistance. Participants will be randomized to antibiotic or no treatment arm. Those randomized to the treatment arm will receive oral antibiotics for 2 days pre-treatment, on the treatment day, and 2 days post-treatment. Participants will return for a follow up appointment approximately 2 weeks after treatment to assess for urinary tract infection (UTI) symptoms. They will be called again at 6 weeks for follow up.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: t
View:

• Female

• Age ≥ 18

• Patient undergoing bladder Botox treatment

Locations
United States
New Jersey
Atlantic Health
RECRUITING
Morristown
Contact Information
Primary
Anastasiya Holubyeva, MD
anastasiya.holubyeva@atlantichealth.org
9739717267
Time Frame
Start Date: 2022-08-16
Estimated Completion Date: 2024-08-16
Participants
Target number of participants: 140
Treatments
Experimental: Antibiotic arm
Antibiotics will be administered for 2 days pre-treatment, on the treatment day, and 2 days post-treatment.
No_intervention: No treatment arm
No antibiotics administered.
Sponsors
Collaborators: Columbia University
Leads: Atlantic Health System

This content was sourced from clinicaltrials.gov

Similar Clinical Trials